The largest database of trusted experimental protocols

17 protocols using dako envision detection kit

1

Immunohistochemical Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining was carried out using the DAKO Envision detection kit (Dako, Carpinteria, CA, USA). In brief, paraffin-embedded tissue blocks were sectioned (4 μm-thick), dried, deparaffinized, and rehydrated. Antigen retrieval was performed in a microwave oven for 15 min in 10 mM citrate buffer (pH 6.0). After cells were embedded in 4% neutral formaldehyde for 2 h, PBS with 0.5% Tween-20 was added for 30 min at room temperature. For all samples, endogenous peroxidase activity was blocked with a 3% H2O2-methanol solution. The slides were blocked with 10% normal goat serum for 10 min and incubated with an appropriately diluted primary antibody overnight at 4°C. The slides were then probed with an HRP-labeled polymer conjugated to an appropriate secondary antibody for 30 min. The antibodies against estrogen receptor (ER), progesterone receptor (PR), HER-2, Ki67, cytokeratin 5/6 (CK5/6) and epidermal growth factor receptor (EGFR) were purchased from Dako (Carpinteria, CA, USA) and the GCS antibody was a gift from Dr. D. Marks (Mayo Clinic Center).
+ Open protocol
+ Expand
2

Immunohistochemical Assessment of PRDM1, Granzyme B, and TIA-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHC staining was carried out using the DAKO EnVision detection kit (Dako, Glostrup, Denmark). Tissue sections were subjected to heat-induced antigen retrieval in EDTA buffer (pH 9.0). A panel of primary antibody including PRDM1 (clone C14A4, cell signaling, Beverly, MA, USA), granzyme B (clone 11F1, Novocastra, Newcastle upon Tyne, England), TIA-1 (clone TIA-1, Coulter, Hialeah, FL, USA), and CD56 (Clone UMAB83, Zhongshan, China) was utilized in our study.
A positive nuclear staining pattern was interpreted as representing PRDM1 immunoreactivity, while the cytoplasmic immunoreactivity for granzyme B or TIA-1 was considered as positive staining. Based on Garcia and Nie's investigations [20 (link), 21 (link)], positive expression of PRDM1 was defined as nuclear staining in 10% or more of the tumour population and was semiquantitatively estimated as follows: negative (no positive cells or <10%), weak (10% to ≤50% positive cells), or strong (>50% to 100% positive cells). Tonsils sample was used as positive control for PRDM1 staining. For the negative control reactions, phosphate buffer saline (PBS) was used instead of the primary antibody.
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of PDGF-C Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following optimization of staining conditions using positive and negative controls, immunohistochemical analysis was carried out using DAKO EnVision detection kit (Dako, Carpinteria, CA). Briefly, tissue array blocks were cut into 4 μm-thick sections, dried, deparaffinized, and rehydrated. Antigen retrieval was performed in a steamer for 40 minutes in 10 mM citrate buffer pH 6.0, and endogenous peroxidase activity was blocked with a 3% H2O2-methanol solution. The slides were blocked with 10% normal goat serum for 10 minutes and were incubated with anti-PDGF-C/GFD Ab (1:200) for one hour at room temperature. The slides were then incubated with HRP-labeled polymer conjugated to secondary antibody for 30 minutes. Diaminobenzidine was used as a chromogen, and the sections were counterstained with Mayer’s hematoxylin.
+ Open protocol
+ Expand
4

Immunohistochemical Assessment of ABCB1 in Medulloblastoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry (IHC) was performed using the Dako Envision Detection kit (DAKO REAL EnVision) [53 (link)]. Sections were counter-stained with haematoxylin (Leica Microsystems). As negative controls, adjacent or similar sections were processed with antibody diluent (Dako). The antibodies (Abs) used to stain the original patient samples with appropriate control for each Ab are summarised in Additional file 2: Table S2.
A total of 27 Nottingham MB patients diagnosed between January 1986 and January 2006 were analysed by IHC. Consent for tumour tissue use was taken in accordance with national tumour banking procedures (UK: 05/MRE/04/70). A second TMA comprising 233 patient samples was obtained from the DKFZ [48 (link)]. Both TMAs were stained with the anti-ABCB1 Ab (C219, 1:40; Calbiochem) and patients with clear evidence of cell membrane staining were scored as positive by three independent reviewers who were blinded to clinical and patient molecular variables.
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of Apoptosis Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumor samples were fixed in 4% formalin overnight and prepared as paraffin-embedded stocks. Hematoxylin and eosin staining and immunohistochemistry were performed according to standard procedures. The slides were incubated with primary antibodies against Ki67 (1:200, Abcam), Bcl-2 (1:100, Abcam), Bax (1:100, Abcam), and cleaved caspase-3 (1:100, Abcam) followed by treatment with HRP-conjugated secondary antibody (Dako, Glostrup, Denmark). Immunoreactivity was visualized with the Dako EnVision™ Detection kit (Dako). The terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was performed following the manufacturer’s instructions (Roche, Basel, Switzerland). Briefly, the slides were digested with proteinase K, blocked with H2O2, and incubated with the terminal deoxynucleotidyl transferase mixture for 60 min. The slides were thoroughly washed, incubated with streptavidin-HRP, and visualized by diaminobenzidine.
+ Open protocol
+ Expand
6

Immunohistochemical Evaluation of HLA-ABC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining of HLA class I was performed on TMAs using HLA-ABC (Clone EMR8-5; 1:200 dilution; Abcam) with Dako EnVision detection kit (Dako, Carpinteria, CA, USA). Some of the IBC cases had been evaluated for HLA-ABC expression in the previous study36 (link), and those cases were re-evaluated during the study. HLA-ABC expression was evaluated in the tumor cell membrane for both intensity and proportion of positive cells. We adopted the interpretation method of HLA class I expression from the study by Na et al.19 (link). The staining intensity was classified into negative, weak positive, and strong positive. Lymphocytes and endothelial cells were used as internal control, and weak positivity was defined as staining weaker than internal control. Staining equivalent or stronger than internal control was considered strong positive. For statistical analysis, high expression was defined as 50% or more tumor cells showing strong positivity. Low expression was defined as < 50% of the tumor cells revealing strong positivity or ≥ 50% showing weak positivity.
+ Open protocol
+ Expand
7

Immunostaining of Disease-Associated Alpha-Synuclein

Check if the same lab product or an alternative is used in the 5 most similar protocols
FFPE tissues were cut into 4.5-µm-thick sections using a microtome and immuno-stained with the monoclonal 5G4 anti-mouse antibody [44 (link)], which labels only the disease-associated αSyn (1:4000; 5 min pre-treatment with 80% formic acid; Roboscreen, Leipzig, Germany). Target retrieval was performed using the DAKO EnVision FLEX Target Retrieval Solution. The DAKO EnVision detection kit, EnVision FLEX peroxidase-blocking solution, 3,3′-Diaminobenzidine chromogen, and EnVision FLEX+ mouse linker (Dako, Glostrup, Denmark) was used to visualize the antibody reactions.
Digital images were obtained with TissueScopeTM LE120 and TissueSnapTM (Huron, Saint Jacobs, ON, Canada) and cropped using HuronViewer software (Figure S1).
+ Open protocol
+ Expand
8

Immunohistochemical Staining of NSCLC Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining was carried out using the DAKO Envision detection kit (Dako, Carpinteria, CA, USA). In brief, paraffin-embedded tissue blocks were sectioned (4 μm-thick), dried, deparaffinized, and rehydrated. Antigen retrieval was performed in a microwave oven for 15 min in 10 mM citrate buffer (pH 6.0). For all samples, endogenous peroxidase activity was blocked with a 3% H2O2-methanol solution. The slides were blocked with 10% normal goat serum for 10 min and incubated with an appropriately diluted primary antibody mouse monoclonal antibody D2-40 (diluted 1:50), anti-PDGF-BB rabbit polyclonal antibody (diluted 1:200) or anti-VEGF-C rabbit polyclonal antibody (diluted 1:100) overnight at 4°C. The slides were then probed with an HRP-labeled polymer conjugated to an appropriate secondary antibody for 30 min. Each step was followed by washing with PBS. Each batch of staining was accompanied by positive and negative control slides. Primary human NSCLC tissues, which are demonstrated to exhibit high levels of PDGF-BB and VEGF-C protein, were used as positive controls. Normal mouse IgG substituted for primary antibody was a negative control.
+ Open protocol
+ Expand
9

Tissue Microarray for Gastric Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
For tissue microarray, we reviewed all H&E-stained slides and representative histological areas were carefully selected and marked on paraffin blocks. From each paraffin block, four primary gastric cancer tissue cores (diameter = 0.6 mm) were taken from the invasive front, both lateral sides, and the luminal surface area of the tumor using AccuMax (IsuAbxis, Seoul, Korea) as previously described [22 (link)]. Immunohistochemistry was performed on formalin-fixed, paraffin-embedded, 4-μm-thick tissue sections using rabbit monoclonal antibody IKKε (D20G4, Cell Signaling Technology, Danvers, MA, USA, 1:50 dilution) and TBK1/NAK (D1B4, Cell Signaling Technology, Danvers, MA, USA, 1:200 dilution). For IKKε, we incubated primary antibody overnight at 4°C and used a DAKO Envision™ Detection Kit (DAKO, Glostrup, Denmark) for 30 minutes. For TBK1, we incubated primary antibody for 15 minutes with Bond-max autoimmunostainer (Leica Biosystem, Melbourne, Australia) using Bond™ Polymer refine detection (DS9800, Vision Biosystems, Melbourne, Australia) according to the manufacturer’s protocol. For the interpretation of IKKε and TBK1 Immunohistochemistry, strong, distinct cytoplasmic staining with membranous accentuation was considered positive.
+ Open protocol
+ Expand
10

Optimized Immunocytochemistry Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six aliquots of isolated cells were spotted onto slides and allowed to dry. The staining procedure was performed with the DAKO Envision Detection Kit (Dako, Germany). Although we included an incubation step with hydrogen peroxide (0.6%) we observed the staining of single immune cells caused by endogen peroxidase catalysed dye conversion in validation experiments. To eliminate this unspecific staining we included a heat-induced epitope retrieval step in citrate buffer (pH 6) presumably resulting in peroxidase inactivation (data not shown). After hydrogen peroxide treatment and blocking of unspecific binding sites with goat serum (Dako) primary pan-cytokeratin antibody (AE1/AE3, 1:500 dilution, Dako) was incubated overnight at 4°C. Secondary antibody and substrate incubation were done according to manufacturer's instructions (Dako) and cells were counterstained with haematoxylin. All staining experiments included negative controls (without primary antibody).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!